U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 13:29:47 GMT 2025
Edited
by admin
on Wed Apr 02 13:29:47 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
ZQL8925JUB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Greziprubart
INN  
Official Name English
STSA-1002
Preferred Name English
immunoglobulin G1-kappa, anti-[Homo sapiens C5 (complement 5) anaphylatoxin (C5a, C5 Pr678-751)], Homo sapiens monoclonal antibody
Common Name English
H-gamma1 heavy chain Homo sapiens (1-449) [VH (Homo sapiens IGHV3-72*01 (88.8%) -(IGHD) -IGHJ5*01 (91.7%) T122>V (113), CDR-IMGT [8.10.10] (26-33.51-60.99-108)) (1-119) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v14 CH2 A1.3, A1
Common Name English
Immunoglobulin G1 [236-alanine,237-alanine], anti-(human complement C5a) (human monoclonal STSA-1002 ?1-chain), disulfide with human monoclonal STSA-1002 ?-chain, dimer
Common Name English
greziprubart [INN]
Common Name English
Code System Code Type Description
FDA UNII
ZQL8925JUB
Created by admin on Wed Apr 02 13:29:47 GMT 2025 , Edited by admin on Wed Apr 02 13:29:47 GMT 2025
PRIMARY
CAS
2894136-80-0
Created by admin on Wed Apr 02 13:29:47 GMT 2025 , Edited by admin on Wed Apr 02 13:29:47 GMT 2025
PRIMARY
INN
13120
Created by admin on Wed Apr 02 13:29:47 GMT 2025 , Edited by admin on Wed Apr 02 13:29:47 GMT 2025
PRIMARY
NCI_THESAURUS
C211833
Created by admin on Wed Apr 02 13:29:47 GMT 2025 , Edited by admin on Wed Apr 02 13:29:47 GMT 2025
PRIMARY
SMS_ID
300000056815
Created by admin on Wed Apr 02 13:29:47 GMT 2025 , Edited by admin on Wed Apr 02 13:29:47 GMT 2025
PRIMARY
From To
1_22 1_98
2_22 2_98
2_146 2_202
2_222 4_219
2_263 2_323
1_146 1_202
2_369 2_427
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
1_222 3_219
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
TARGET->LIGAND
IN-VITRO
TARGET -> INHIBITOR
IN-VITRO
Related Record Type Details
ACTIVE MOIETY
PRECLINICAL

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_449] [2_449] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL